J&J kicks off $5 billion clinical diagnostics unit sale: sources

By Soyoung Kim and Greg Roumeliotis and Jessica Toonkel NEW YORK (Reuters) – Johnson & Johnson has launched a sale process for its Ortho Clinical Diagnostics unit, which makes blood screening equipment and laboratory blood tests and could fetch around $5 billion, three people familiar with the matter said on Friday. J&J has asked JPMorgan Chase & Co to run the sale and is preparing to send detailed financial information in coming weeks to potential buyers, including some of the world's largest private equity firms and a number of healthcare companies, the people said. …